A new assay has been developed for the faster, cheaper and less labour-intensive detection of replicating latent HIV in infected individuals.
A team from the Scripps Research Institute have determined the structure of clade C HIV-1 envelope glycoprotein, an immunogen that could be utilized in a future HIV vaccine.
Researchers have utilized mathematical modelling to assess whether US goals for HIV transmission and incidence are possible, discovering a serious reduction is achievable if other key goals are met.
In this interview, Joop Arends discusses his thoughts on the future of diagnosis and management of hepatitis C, and also gives us his highlights from ECCMID.
CRISPR/Cas9 has been demonstrated to excise HIV-1 DNA from host tissues in vivo according to new research; this marks a major step towards a permanent cure for HIV infection.
This Editorial discusses a Health Economics and Outcomes Research (HEOR) approach to use a formal comparative effectiveness analysis and a network meta-analysis for both first- and second-line ART regimens for adults, adolescents and children.
Given the ability of the microbiota to instruct the immune system and control the inflammatory response, the authors discuss the potential of targeting the microbiota to improve the immune recovery and dampen inflammation during HIV infection.
Researchers have demonstrated in mouse models that HIV can persist in infected macrophages despite antiretroviral therapy, suggesting a new cell reservoir.
Researchers have applied concepts from financial mathematical models to help predict the evolution of HIV proteins with the hope this could improve vaccine design.
This opinion piece discusses the many challenges inherent in caring for HIV+ individuals with new-onset seizure. With more questions than answers in both resource-limited settings and more developed medical environments what do we need to elucidate going forwards?
